# Crafoord Capital Partners

> Crafoord Capital Partners is a VC fund backing Internet, Health Care and Generative AI. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 2
- Last investment: Feb 2026
- Lead investor: 0%
- Last updated: Aug 2026

Crafoord Capital Partners is a investment firm.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Internet | 1 | 50% |
| Health Care | 1 | 50% |
| Generative AI | 1 | 50% |
| Medical Device | 1 | 50% |
| Health Diagnostics | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Post-IPO Debt | 1 | 50% |
| Post-IPO Equity | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Senzime | Senzime develops unique patient-oriented monitoring systems that make it possible to assess patients' biochemical and physiological processes before, during and after surgery. The portfolio of technologies includes bedside systems that enable automated and continuous monitoring of life-critical substances such as glucose and lactate in bothblood and tissues, as well as systems to monitor patients’ neuromuscular function perioperatively and in the intensive care medicine setting. The solutions are designed to ensure maximum patient benefit, reduce complications associated with surgery and anesthesia, and decrease health care costs. Senzime operates in growing markets that in Europe and the United States are valued in excess of SEK 10 billion. The company's shares are listed on Nasdaq First North (ticker SEZI). FNCA is Certified Adviser for Senzime. | $5.6M | Post-IPO Debt | Feb 18, 2026 |  |
| H100 Group | H100 is a data-driven, scalable model to optimize user health journeys by integrating digital health services, professional coaching, and AI-enhanced insights. | $2.2M | Post-IPO Equity | May 26, 2025 |  |

2 of 2 investments shown.

## Co-investors
- [Alundo Invest](https://shizune.co/investors/profile/alundo-invest) — VC Fund, 1 deal together
- DBT — VC Fund, 1 deal together
- Race Venture Scandinavia — VC Fund, 1 deal together
- [Segulah Advisor](https://shizune.co/investors/profile/segulah-advisor) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [BNP Paribas](https://shizune.co/investors/profile/bnp-paribas) — VC Fund
- [Intesa Sanpaolo](https://shizune.co/investors/profile/intesa-sanpaolo) — VC Fund
- [UniCredit](https://shizune.co/investors/profile/unicredit) — VC Fund

## FAQ

### What does Crafoord Capital Partners invest in?

Crafoord Capital Partners invests primarily in Internet, Health Care and Generative AI startups, most often at Post-IPO Debt and Post-IPO Equity stage. Most of the 2 investments tracked by Shizune back companies in Sweden. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Crafoord Capital Partners last invest?

The most recent investment recorded for Crafoord Capital Partners closed in Feb 2026. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co